We investigated whether M 2 muscarinic receptor activation opposes isoproterenolinduced relaxation in mouse urinary bladder and whether endogenous acetylcholine acts through a similar M 2 mechanism. When measured in urinary bladder from M 3 receptor knockout mice, the muscarinic agonist oxotremorine-M elicited only very weak contractions. In the presence of α,ß-methylene ATP (10 µM) and isoproterenol (1 µM), however, oxotremorine-M elicited a robust contractile response. This response was completely absent in bladder from M 2 /M 3 double knockout mice, indicating that activation of the M 2 receptor inhibits the relaxant effect of isoproterenol on the contraction to α,ß-methylene ATP. Similar results were obtained when PGF 2α was used as the contractile agent, but not when serotonin was used. Electrical field stimulation of the urinary bladder from wild type mouse elicited contractions that were inhibited 20% by atropine and 40% by desensitization with α,ß-methylene ATP. When measured in the presence of α,ß-methylene ATP to desensitize the purinergic component of contraction, isoproterenol exhibited moderately greater relaxant activity in field stimulated bladder from the M 2 knockout mouse compared to that observed in wild type bladder. This differential relaxant effect of isoproterenol was greatly increased in the presence of physostigmine. In contrast, no differential effects were noted for isoproterenol in similar experiments on bladders from M 3 knockout and M 2 /M 3 double knockout mice in the presence of physostigmine. Our results suggest that neuronally released acetylcholine acts on the M 2 muscarinic receptor to inhibit the relaxant effect of isoproterenol on the minor, cholinergic component of contraction in the field stimulated mouse urinary bladder.
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INTRODUCTION
Muscarinic receptors play an important role in human urinary bladder function by eliciting contraction of the reservoir and relaxation of the outlet (de Groat and Yoshimura, 2001) .
With regard to the former, most investigators assume a major role for the M 3 receptor because the pharmacological profile of the contractile response of isolated bladder strips from various species exhibits an M 3 character (Noronha-Blob et al., 1989; Longhurst et al., 1995; Choppin and Eglen, 2001) , and the response is almost completely lost in urinary bladder from M 3 KO mice (Matsui et al., 2000) . These observations have led many to question whether the more abundant M 2 receptor has any substantial physiological function in contraction of the urinary bladder.
This issue seems enigmatic when one considers the abundance of signaling mechanisms for the M 2 receptor in smooth muscle. The M 2 receptor mediates an inhibition of adenylyl cyclase and opposes the increase in cAMP elicited by the ß-adrenoceptor (Noronha-Blob et al., 1989) . This mechanism accounts for M 2 receptor mediated inhibition of the relaxant effect of isoproterenol (disinhibition of contraction) in gastrointestinal (Thomas et al., 1993; Thomas and Ehlert, 1994) and urinary bladder smooth muscle (Hegde et al., 1997; Matsui et al., 2003; Ehlert et al., 2005) . Also, the M 2 receptor mediates a nonselective cation conductance (Bolton and Zholos, 1997) and an inhibition of Ca 2+ activated K channels (Cole et al., 1989; Kume et al., 1992; Wade and Sims, 1993) , and these effects would be expected to promote contraction.
However, when the contractile response to muscarinic agonists is measured under conditions of a simultaneous activation of both M 2 and M 3 receptors, the profile for competitive antagonism always resembles that of the M 3 receptor with little hint of an M 2 contribution, even in the presence of isoproterenol when an M 2 receptor mediated disinhibition of contraction would be expected to occur (Choppin, 2002; Ehlert et al., 2005) . The key to understanding this enigma lies in the conditional nature of M 2 signaling mechanisms. M 2 receptor mediated inhibition of relaxation requires a contraction elicited by a Ca 2+ mobilizing receptor in the first place;
otherwise, there is no contraction to be relaxed by the ß-adrenoceptor, and no ß-adrenoceptor This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. are also dependent on activation of a Ca 2+ mobilizing receptor. It has been shown that a response mediated by a directly acting receptor, like the M 3 , and a receptor whose action is contingent upon activation of the former exhibits a pharmacological profile of the directly acting receptor in competitive antagonist studies (Sawyer and Ehlert, 1999b; Ehlert, 2003) . Thus, the M 3 profile of the muscarinic contractile response in urinary bladder is not only consistent with a pure M 3 response, but also with an interaction between a conditionally acting M 2 receptor and a directly acting M 3 . Moreover, the near complete loss of muscarinic contractile function in urinary bladder from M 3 KO mouse is also consistent with both hypotheses.
To discriminate between these two possibilities, our lab developed a procedure for measuring the ability of the M 2 receptor to disinhibit contractions elicited by other receptors, and we and others have used this technique to show that activation of the M 2 receptor opposes the relaxant effects of isoproterenol and forskolin on contractions elicited by a variety of spasmogens in gastrointestinal and urinary bladder smooth muscle (Thomas et al., 1993; Thomas and Ehlert, 1994; Hegde et al., 1997; Ehlert et al., 2005) . These experiments were carried out on isolated smooth muscle with exogenously applied muscarinic agonist, and hence, the results do not prove that endogenous acetylcholine released from parasympathetic nerves can mediate these M 2 effects. To address this issue, we have used electrical field stimulation and P2X receptor-
induced neuronal activation to demonstrate that acetylcholine released from nerves in gastrointestinal smooth muscle acts on the M 2 receptor to oppose the relaxant effects of isoproterenol on neurogenic contractions mediated by the M 3 receptor (Sawyer and Ehlert, 1999a; Sawyer et al., 2000) .
In the present report, we have addressed these issues in mouse urinary bladder from wild type and muscarinic receptor knockout mice. We show that when applied exogenously, the muscarinic agonist oxotremorine-M acts on the M 2 receptor to oppose the relaxant effects of isoproterenol on contractions elicited by exogenous PGF 2α and the purinergic agonist α,ß mice were generated as described in Matsui et al. (2002) and Matsui et al. (2000) , respectively. (Ehlert et al., 2005) . The tissue was allowed to equilibrate for at least an hour, during which time the resting tension was adjusted to a load of 1 g. Next, the contractile response to three test doses to KCl (50 mM) were measured. After each test dose, the tissue was washed and allowed to rest for 10 min.
The contractions to KCl were usually biphasic, consisting of an initial rapid peak that declined initially and then slowly rose to a stable plateau. The contractile response to KCl was calculated as the stable plateau value minus the initial resting tension. The contractile response to other agents were normalized relative to the largest response to KCl, which was usually occurred with the second or third test dose, both of which were usually similar.
The concentration-response curve to mATP was measured using a noncumulative
technique. An aliquot of the agonist was added to the bath, and response was calculated as the JPET #121756 8 peak contraction that was achieved usually within a few sec minus the initial resting tension, which was adjusted to a mass equivalent of approximately 1 g. The bladder was washed two to three times, depending upon the agonist concentration, and allowed to rest for 10 min prior to the next measurement. The concentrations of agonist were added to the bath in order of increasing concentration to avoid the effect of desensitization on the response to low concentrations. In preliminary experiments, we found that the contraction elicited by mATP (30 µM) did not wane when measured repetitively (five times) using this schedule.
In some experiments on urinary bladder from M 3 KO mice, we measured the concentration-response curve to oxotremorine-M in the presence of isoproterenol (1 µM) and a non-muscarinic contractile agent (i.e., mATP, PGF 2α or serotonin) using a noncumulative technique. At the start of the experiment, two responses to the non-muscarinic contractile agonist
were measured using the noncumulative method described above. The concentration of agonist was chosen so that it elicited a near maximal response (mATP, 30 µM; PGF 2α , 1 µM; and serotonin, 5 µM). Then the responses to increasing concentrations of oxotremorine-M were measured using the following strategy. First, isoproterenol was added to the bath at a final concentration of 1 µM. After two min, oxotremorine-M was added and the preparation was allowed to equilibrate for approximately 20 -30 sec in the presence of both oxotremorine-M and isoproterenol. Then, the non-muscarinic contractile agent was added, and its peak (mATP) or stable response (PGF 2α and serotonin) was recorded. The preparation was washed two to three times and allowed to rest for approximately 10 min. This process was repeated on a 15 min cycle with increasing concentrations of oxotremorine-M and with the concentrations of isoproterenol and non-muscarinic contractile agent remaining constant. The response to oxotremorine-M was calculated as the measured response to the non-muscarinic contractile agent after isoproterenol and oxotremorine-M had been added to the bath minus the initial resting tension at the start of the experiment.
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JPET Fast Forward. Field stimulated urinary bladder: The whole urinary bladder was set up as described above and mounted between two platinum ring electrodes spaced approximately 3.5 cm apart. The tissue was allowed to equilibrate for at least an hour, and three test doses to KCl were measured as described above. Three test trains of stimulation (0.2 Hz, 2 msec and 100 V), each for 5 min,
were applied, and the tissue was washed and allowed to rest for five min after each stimulation.
Under these conditions, the urinary bladder generated a train of twitch contractions, each twitch characterized by an initial rapid and transient contraction that decayed rapidly. The twitch response was calculated as the maximum peak tension minus the resting tension immediately before the pulse. These contractions were normalized relative to that elicited by KCl (50 mM).
Many, but not all, of the urinary bladders that we obtained from male M 3 KO and M 2 /M 3 KO mice did not respond to field stimulation, perhaps because of the prominent urinary bladder distension that occurs in male mice lacking the M 3 receptor (Matsui et al., 2000) , which could disrupt nerves innervating the bladder. Consequently, we used female mice for electrical field stimulation in M 3 KO and M 2 /M 3 KO mice. The relaxant response to isoproterenol was measured using a cumulative technique. Electrical field stimulation was applied to the bladder, and after one min, isoproterenol was added to the bath. Additional concentrations of isoproterenol were added at one-min intervals in order of increasing concentration. The contractile response in the presence of isoproterenol was calculated as the average of the heights of the last four twitches of the one-min cycle. Following electrical field stimulation, the urinary bladder was washed three times and allowed to equilibrate for 30 min prior to additional measurements. In experiments utilizing mATP or antagonists, these were applied to the tissue 30 min prior to field stimulation.
Analysis of agonist concentration response curves:
The maximal response (E max ), concentration of agonist eliciting half-maximal response (EC 50 ) and Hill slope (n) were estimated from the agonist concentration-response curve by nonlinear regression analysis using Prism (GraphPad Software, Inc., San Diego). The significance of difference between the parameter estimates obtained on urinary bladders for wild type and M 2 KO mice was determined using a Student's T This article has not been copyedited and formatted. The final version may differ from this version.
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Contraction of urinary bladder to exogenous agonists:
We investigated the ability of the purinergic agonist mATP to elicit contractions in urinary bladder from wild type, M 2 KO, M 3 KO and M 2 /M 3 KO mice. In wild type mice, mATP elicited powerful phasic contractions that usually reached a peak within a few seconds of application to the organ bath, and thereafter, the contraction slowly waned. A plot of the peak contraction, expressed relative to that elicited by KCl (50 mM), against the Log molar concentration of mATP is shown in Figure 1 . The mean value ± SEM for the pEC 50 and E max values of mATP in the urinary bladder from wild type (6.09
± .21 and 85 ± 13%), M 2 KO (6.14 ± .11 and 87 ± 12%), M 3 KO (5.85 ± .14 and 87 ± 22%) and M 2 /M 3 KO mice (6.06 ± .12 and 79 ± 11%) were similar.
To investigate the role of the M 2 receptor in opposing the relaxant effect of isoproterenol on contraction elicited to other contractile agents we used the following strategy, which is a modification of our prior method utilizing a cumulative technique for measuring the agonist concentration-response curve (Thomas et al., 1993; Ehlert et al., 2005) . Here, we use a noncumulative technique because the response to mATP is transient. Since there are no readily available muscarinic agonists that activate M 2 receptors with high selectivity, we measured contraction to the muscarinic agonist oxotremorine-M in urinary bladder from M 3 KO mice, which exhibits only very weak M 2 receptor-mediated contractions to muscarinic agonists (Matsui et al., 2000; Ehlert et al., 2005) . Thus, under these conditions, we can be assured that the response to muscarinic stimulation is due to activation of the M 2 receptor only, and not both the M 2 and M 3 receptors. We measured contractions in the presence of isoproterenol (1.0 µM) and a non-muscarinic contractile agent (mATP, PGF 2α or serotonin). In combination, the contractile agent and isoproterenol had little or no net effect because their actions oppose one another.
However, if activation of the M 2 receptor inhibits the relaxant effect of isoproterenol on the contractile agent, it should be possible to measure muscarinic agonist induced contractions through the M 2 receptor that are characterized by an E max equivalent to contraction elicited by the This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. non-muscarinic contractile agent (e.g., mATP) by itself. Figure 2B shows that oxotremorine-M elicits a potent contractile response in M 3 KO mice when measured in the presence of mATP (30 µM) and isoproterenol (1 µM). This response was completely absent in urinary bladder from the M 2 /M 3 KO mouse illustrating that the response is mediated by the M 2 receptor. Moreover, the E max is much greater than the weak M 2 response measured in M 3 KO mice in the absence of isoproterenol and mATP (Figure 2A) , illustrating that the mechanism is consistent with an M 2 receptor mediated disinhibition of the mATP induced contraction. Also, the E max of the contraction is approximately the same as the contraction to mATP by itself, which is also consistent with the M 2 disinhibitory mechanism. Similar results were obtained with PGF 2α
( Figure 2C ), but little or no disinhibitory mechanism was detected when serotonin was used as the non-muscarinic contractile agent (data not shown).
To determine if the action of isoproterenol was altered in muscarinic receptor KO mice, and 70 ± 2%) were approximately the same. We also measured the relaxant effect of isoproterenol against KCl induced contractions and found no difference in its pEC 50 value or maximal inhibitory effect in wild type (7.68 ± .15 and 48 ± 4%) and M 2 KO mice (7.62 ± .39 and 52 ± 11%), respectively ( Figure 3B ). 13 approximately (15%) by direct activation of the muscle. When normalized relative to the contraction elicited by 50 mM KCl, the field stimulated contraction in urinary bladder from wild type mice (25.9 ± 1.4%) was not significantly different from that measured in M 2 KO mice (27.6 ± 2.0) (P = 0.50, df = 38). In urinary bladder from wild type mice, prior treatment with mATP (0.1 mM) for 30 min caused a significant 38 ± 3.5% inhibition of field stimulated contractions (P = 3.5 x 10 -5 ), whereas treatment with atropine 1 µM only caused a small but significant 15 ± 4.1 % inhibition (P = 0.024). Treatment with both mATP (0.1 mM) and atropine (1.0 µM) caused a highly significant, near additive 69 ± 2.1% inhibition of the contraction (P = 9.5 x 10 -5 ). We also found that methoxamine (1 µM), indomethacin (1 µM), or ketansarin (1 µM) caused no further inhibition of the residual contraction that persisted in the presence of atropine and mATP, indicating that the residual response is not mediated by prostanoids, norepinephrine acting on α-adrenoceptors or serotonin acting on 5-HT 2 receptors. Atropine and mATP were a little less effective at inhibiting field stimulated contraction in urinary bladder from the M 2 KO mouse, and this difference in mouse strains was significant with respect to mATP (P = 0.016), but not for atropine. The results described above are summarized in Figure 4 .
Effects of isoproterenol on the field stimulated urinary bladder:
We reasoned that if neuronally released acetylcholine acts on the M 2 receptor to oppose ß-adrenoceptor-mediated relaxation, then the relaxant effect of isoproterenol should be greater in urinary bladder from the M 2 KO mouse relative to that from the wild type mouse when measured under conditions of field stimulation. To test this postulate, we measured the effects of various concentrations of isoproterenol on the field stimulated urinary bladder from wild type and M 2 KO mice. As shown in Figure 5A , however, there was no difference in the mean ± SEM values for the pEC 50 and maximal inhibitory effect of isoproterenol in urinary bladder from wild type (7.6 ± 0.2 and 90 ± 2%) and M 2 KO (7.7 ± .1 and 87 ± 3%) mice, respectively. These results reveal no role for the M 2 receptor in mediating a disinhibition of contraction via neuronally released acetylcholine.
This article has not been copyedited and formatted. The final version may differ from this version. Figure 5B ). Under these conditions, isoproterenol exhibited a small, but statistically significant greater relaxant potency (P = .044) at inhibiting field stimulated contractions in the urinary bladder from M 2 KO mice (pEC 50 = 7.39 ± .18) compared to that from wild type mice (pEC 50 = 6.95 ± .17). This difference corresponded to a 2.6-fold increase in potency. There was little difference in the maximal relaxant effect of isoproterenol in wild type ± .1) compared to that observed in the wild type mouse (pEC 50 = 7.5 ± .2) (see Figure 7A ). This difference in pEC 50 was significant (P = 0.037). Also, the maximal relaxant effect of isoproterenol in urinary bladder from M 2 KO mice (90 ± 1.2%) was significantly greater than that observed in wild type mice (68 ± 4.3%) (P = 0.0082). We repeated these experiments in urinary bladder that had been treated with mATP (0.1 mM) to desensitize the purinergic component and to eliminate its contribution to contraction. In the presence of mATP, isoproterenol and forskolin on contractions elicited to PGF 2α and M 3 receptor activation (Ehlert et al., 2005) . In our prior studies with PGF 2α , we used a cumulative technique for measuring the concentration-response curve. Here we repeated our experiments with PGF 2α using a noncumulative technique and observed an even greater M 2 response to oxotremorine-M.
Evidence from a variety of studies on the urinary bladder from the mouse (Vial and Evans, 2000) and other species indicates that mATP elicits contraction through the P2X 1 subtype. Our observation that the contraction to mATP is transient and desensitizes quickly is consistent with a P2X 1 mechanism since these ligand gated ion channels are known to desensitize rapidly to mATP. This rapid desensitization requires a non-cumulative method for measurement of the concentration-response curve to mATP and also for measurement of the role of the M 2 receptor in opposing the relaxant effect of isoproterenol on mATP induced contractions.
The results of our experiments on the components of the electrically induced contraction of the mouse urinary bladder differ from those of Ekman et al. (2006) whereas the remainder can be attributed to purinergic contractions (Westfall et al., 1983; Kennedy et al., 2007) . Similarly, in rat the cholinergic component of the electrogenic contraction in the urinary bladder is small (Carpenter, 1963) .
We found little difference in the relaxant effect of isoproterenol against field stimulated contractions in urinary bladder from wild type and M 2 KO mouse indicating that overall, M 2 receptor activation by neuronally release acetylcholine has little influence in opposing the relaxant action of isoproterenol on neurogenic contractions of the mouse urinary bladder.
Nevertheless, we did observe a small but significant role for the M 2 receptor when the purinergic component of contraction was eliminated by desensitization with mATP. When the residual, non-purinergic component of the contraction was enhanced by treatment with physostigmine, the relaxant action of isoproterenol was much greater in urinary bladder from the M 2 KO mouse compared to that from the wild type mouse, indicating that neuronally released acetylcholine acts on the M 2 receptor to oppose the relaxant action of isoproterenol. The increased relaxant action of isoproterenol in urinary bladder from the M 2 KO mouse cannot be attributed to enhanced ß-adrenoceptor-mediated relaxation in the M 2 KO mouse because there was no difference in the relaxant effects of isoproterenol against KCl-and mATP-induced contractions in these two mouse strains. It might be argued that in the presence of physostigmine, neuronally released acetylcholine accumulates and diffuses to M 2 receptors that oppose the relaxant effect of isoproterenol on purinergic contractions. This mechanism might explain the large increase in the relaxant effect of isoproterenol in M 2 KO mouse urinary bladder compared to wild type in the presence of physostigmine. However, this increase in the relaxant potency was not observed in the urinary bladder from the M 2 /M 3 KO mouse compared to that from the M 3 KO mouse when This article has not been copyedited and formatted. The final version may differ from this version.
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Our hypothesis that neuronally released acetylcholine acts on the M 2 receptor to inhibit ß-adrenoceptor-mediated relaxation of M 3 receptor-mediated contractions implies that it should be possible to demonstrate this mechanism with bath applied muscarinic agonist. We have previously shown that isoproterenol is more effective at inhibiting contractions of the urinary bladder from the M 2 KO mouse compared to those from wild type mouse when equiactive muscarinic stimuli are compared (Matsui et al., 2003) . In contrast, there is no difference in the relaxant effect of isoproterenol against noncholinergic stimuli in urinary bladder from wild type and M 2 KO mice.
We have previously noted that the effectiveness of isoproterenol for relaxing electrical field stimulated contractions of the guinea pig ileum is greatly enhanced in ileum treated with pertussis toxin to interrupt M 2 receptor signaling (Sawyer and Ehlert, 1999a) . Pertussis toxin treatment has no inhibitory effect on muscarinic agonist induced contractions of the guinea pig ileum, nor on field stimulated contractions. Pertussis toxin treatment does, however, increase the relaxant effect of isoproterenol against muscarinic agonist induced contraction of the guinea pig This article has not been copyedited and formatted. The final version may differ from this version. (Kilbinger et al., 1984) . As suggested above, it may be that in the mouse urinary bladder, the disinhibitory role of the M 2 receptor is also selective for M 3 receptor mediated contractions.
Although the disinhibitory role of the M 2 receptor in mouse urinary bladder is rather small, cholinergic contractions only make up a small component of the neurogenic contraction in the mouse under our conditions of electrical field stimulation. In human urinary bladder, the contribution of acetylcholine to neurogenic contractions is much greater (Sibley, 1984) . Thus, it is possible that the disinhibitory role that we describe here for the M 2 receptor in mouse bladder is much greater in the human urinary bladder where cholinergic contractions predominate.
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